| Pioglitazone Attenuates Cardiac Fibrosis and Hypertrophy in a Rat Model of Diabetic Nephropathy. | |
| | |
MedLine Citation:
|
PMID: 22261714 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Pioglitazone has been demonstrated to have beneficial effects on cardiovascular outcomes. However, little is known about its effect on cardiac remodeling associated with diabetic nephropathy. Therefore, this study was designed to study the effects of pioglitazone on cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy. For this purpose, male Wistar albino rats were randomly assigned into 4 groups (n = 10 per group): normal (N) group, diabetic (D) group, diabetic nephropathic (DN) group received an equal amount of vehicle (0.5% carboxy methyl cellulose), and diabetic nephropathic group treated by oral administration of pioglitazone (10 mg/kg per d) for 4 weeks. Diabetic nephropathy was induced by subtotal nephrectomy plus streptozotocin (STZ) injection. The results revealed that DN rats showed excessive deposition of collagen fibers in their cardiac tissue, along with a marked myocyte hypertrophy. This was associated with a dramatic upregulation of cardiac transforming growth factor-β1 (TGF-β1) gene. Furthermore, the gene expression of matrix metalloproteinase 2 (MMP-2) decreased, while the gene expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) increased in the hearts of DN rats. In addition, enhanced lipid peroxidation and myocardial injury, evidenced by a significant increase in their serum creatine kinase-MB level were observed in DN rats. All these abnormalities were ameliorated by pioglitazone administration. Our findings suggest that upregulation of cardiac TGF-β1 gene along with the imbalance between MMP-2 and TIMP-2 expressions is critically involved in cardiac fibrosis associated with diabetic nephropathy. Pioglitazone can ameliorate cardiac remodeling by suppressing the gene expression of TGF-β1 and regulating the MMP-2/TIMP-2 system. |
| | |
Authors:
|
Rania A Elrashidy; Mervat E Asker; Hoda E Mohamed |
Related Documents
:
|
18602824 - Health-promoting effects of bovine colostrum in type 2 diabetic patients can reduce blo... 9571604 - Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabet... 15936464 - Apolipoprotein e4 allele and the risk of cad death in type 2 diabetes mellitus with isc... 1765754 - Hypertriglyceridemia in diabetes. an approach to management. 15749384 - Effects of oxidative stress on adiponectin secretion and lactate production in 3t3-l1 a... 3886464 - Products of therapeutic insulins in the blood of insulin-dependent (type i) diabetic pa... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-18 |
Journal Detail:
|
Title: Journal of cardiovascular pharmacology and therapeutics Volume: - ISSN: 1940-4034 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-20 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9602617 Medline TA: J Cardiovasc Pharmacol Ther Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: An Interdisciplinary Wound Team in Home Health: The Role of the Physical Therapist in Wound Care.
Next Document: Suppression of Rac1 activity at the apical membrane of MDCK cells is essential for cyst structure ma...